BACKGROUND: Although syringe distribution is effective in preventing HIV transmission among injecting drug users (IDUs), there is little evidence on the required coverage to substantially reduce HIV transmission. METHODS: A mathematical model is developed to explore the relationship between the endemic HIV prevalence among IDUs and the coverage of syringe distribution. Data from IDU populations in the United Kingdom and Belarus are used to explore the implications of increasing coverage and the effect of changes in other behaviors. RESULTS: Projections suggest that there is a coverage threshold, which, if reached, could lead to substantial decreases in HIV prevalence. The threshold largely depends on the frequency that IDUs inject and (safely) reuse their syringes, and corresponds to less than 4 syringe-sharing events per IDU per month. Other factors, such as the injecting cessation rate and efficacy of syringe cleaning, only have substantial impact near threshold coverage levels. CONCLUSIONS: Our results support a policy of increasing the coverage of syringe distribution but highlight the difficulty in producing a universal coverage target. Great public health benefit could be conferred by encouraging the safe reuse of an IDU's own syringes and small stable injecting groups. Policies that discourage this will negate the impact of syringe distribution interventions.
BACKGROUND: Although syringe distribution is effective in preventing HIV transmission among injecting drug users (IDUs), there is little evidence on the required coverage to substantially reduce HIV transmission. METHODS: A mathematical model is developed to explore the relationship between the endemic HIV prevalence among IDUs and the coverage of syringe distribution. Data from IDU populations in the United Kingdom and Belarus are used to explore the implications of increasing coverage and the effect of changes in other behaviors. RESULTS: Projections suggest that there is a coverage threshold, which, if reached, could lead to substantial decreases in HIV prevalence. The threshold largely depends on the frequency that IDUs inject and (safely) reuse their syringes, and corresponds to less than 4 syringe-sharing events per IDU per month. Other factors, such as the injecting cessation rate and efficacy of syringe cleaning, only have substantial impact near threshold coverage levels. CONCLUSIONS: Our results support a policy of increasing the coverage of syringe distribution but highlight the difficulty in producing a universal coverage target. Great public health benefit could be conferred by encouraging the safe reuse of an IDU's own syringes and small stable injecting groups. Policies that discourage this will negate the impact of syringe distribution interventions.
Authors: Barbara Tempalski; Hannah L Cooper; Samuel R Friedman; Don C Des Jarlais; Joanne Brady; Karla Gostnell Journal: Int J Drug Policy Date: 2008-03-04
Authors: Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper Journal: Ann Epidemiol Date: 2014-01-24 Impact factor: 3.797
Authors: Sean T Allen; Rebecca Hamilton White; Allison O'Rourke; Kristin E Schneider; Brian W Weir; Gregory M Lucas; Michael E Kilkenny; Susan G Sherman Journal: AIDS Behav Date: 2021-04-22
Authors: Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson Journal: BMJ Open Date: 2012-10-18 Impact factor: 2.692
Authors: Don C Des Jarlais; Jonathan P Feelemyer; Shilpa N Modi; Abu Abdul-Quader; Holly Hagan Journal: BMC Public Health Date: 2013-01-19 Impact factor: 3.295